Avior Wealth Management’s Indivior Pharmaceuticals INDV Stock Holding History

Avior Wealth Management’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$272K	Buy	+7,585	New	+$286K	0.01%	690

Other funds holding INDV

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

FIA

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

TWCA

Two West Capital Advisors Overland Park, Kansas $201M AUM 9.67% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Avior Wealth Management's INDV Position: Q3 2026 in Review

Avior Wealth Management opened a new position in Indivior Pharmaceuticals (INDV) in Q3 2026: 7,585 shares worth $272K. The stake represents 0.01% of the portfolio and ranks #690 among its holdings.

25 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

Avior Wealth Management held 7,585 shares of Indivior Pharmaceuticals worth $272K as of Q3 2026.
Indivior Pharmaceuticals was a new Avior Wealth Management position in Q3 2026.
Indivior Pharmaceuticals made up 0.01% of Avior Wealth Management's portfolio in Q3 2026, its #690 holding.
25 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Avior Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.